- Conditions: Prevention of Pregnancy; Postpartum Contraception
Interventions: Drug: Levonorgestrel IUS or Copper T IUD; Drug: Levonorgestrel IUS or Copper T IUD
Sponsors: Oregon Health and Science University; Oregon Health and Science University; Society of Family Planning
Recruiting - verified May 2012 - Condition: Copper Deficiency
Intervention: Dietary Supplement: Copper gluconate
Sponsors: Emory University; Emory University
Recruiting - verified July 2010 - Conditions: Breast Cancer; Stage IV Breast Cancer
Interventions: Procedure: positron emission tomography; Radiation: copper Cu 64-DOTA-trastuzumab; Procedure: Biopsy; Other: Immunohistochemistry staining method; Other: laboratory biomarker analysis; Genetic: mutation analysis
Sponsors: City of Hope Medical Center; City of Hope Medical Center
Recruiting - verified May 2012 - Conditions: Menkes Disease; Occipital Horn Syndrome; Unexplained Copper Deficiency
Intervention: Drug: Copper Histidine
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified September 2011 - Condition: Cervical Cancer
Interventions: Drug: parenteral chemotherapy; Other: imaging biomarker analysis; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Radiation: copper Cu 64-ATSM; Radiation: fludeoxyglucose F 18; Radiation: radiation therapy
Sponsors: American College of Radiology Imaging Network; American College of Radiology Imaging Network
Recruiting - verified March 2012
 |
Copper Clinical Trials |
